Haoyi Zhou
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types.
Journal: Cell stem cell
Published: April 10, 2026
Nano-enabled spatially selective protein degradation modulates lactate metabolism to potentiate antitumor immunity in liver cancer.
Journal: Nature nanotechnology
Published: December 28, 2024
68Ga-grazytracer PET for noninvasive assessment of response to immunotherapy in solid tumors and lymphomas: a phase 1/2 clinical trial.
Journal: Nature communications
Published: July 02, 2024
Targeted protein degradation combined with PET imaging reveals the role of host PD-L1 in determining anti-PD-1 therapy efficacy.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 05, 2024
Annotation of CD8+ T-cell function via ICAM-1 imaging identifies FAK inhibition as an adjuvant to augment the antitumor immunity of radiotherapy.
Journal: Theranostics
Published: October 02, 2023
Noninvasive interrogation of CD8+ T cell effector function for monitoring early tumor responses to immunotherapy.
Journal: The Journal of clinical investigation
Published: April 14, 2022
Galectin expression detected by 68Ga-galectracer PET as a predictive biomarker of radiotherapy resistance.
Journal: European journal of nuclear medicine and molecular imaging
Published: November 06, 2021
ICAM-1 orchestrates the abscopal effect of tumor radiotherapy.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 31, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026